Log In
Print
BCIQ
Print
Print this Print this
 

CT-1578

  Manage Alerts
Collapse Summary General Information
Company Cell Therapeutics Inc.
DescriptionJanus kinase-2 (JAK-2) inhibitor and has activity against FMS-like tyrosine kinase 3 (FLT3; CD135) and colony-stimulating factor 1 receptor (CSF1R; C-FMS; CD115)
Molecular Target Janus kinase-2 (JAK-2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today